Description
A thrombopoietin receptor agonist (EC50 = 0.27 µM) and iron chelator; It increases STAT5 phosphorylation in N2C-Tpo cells at 30 µM and p42/44 MAPK phosphorylation at 10 µM; stimulates megakaryocytopoiesis in human primary bone marrow cells; increases platelet production in chimpanzees at 10 mg/kg per day for five days; binds to iron (III) and mobilizes cellular iron and ferritin in H9C2, Huh7, and RINm5F cells
Formal name: 3’-[2-[(2Z)-1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic acid
Synonyms: SB 497115
Molecular weight: 442.5
CAS: 496775-61-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Blood|Acute Phase Reactants||Research Area|Immunology & Inflammation|Innate Immunity